Literature DB >> 31062858

Identification of differentially expressed gene sets using the Generalized Berk-Jones statistic.

Sheila M Gaynor1,2, Ryan Sun1, Xihong Lin1, John Quackenbush1,2.   

Abstract

MOTIVATION: Cancer genomics studies frequently aim to identify genes that are differentially expressed between clinically distinct patient subgroups, generally by testing single genes one at a time. However, the results of any individual transcriptomic study are often not fully reproducible. A particular challenge impeding statistical analysis is the difficulty of distinguishing between differential expression comprising part of the genomic disease etiology and that induced by downstream effects. More robust analytical approaches that are well-powered to detect potentially causative genes, are less prone to discovering spurious associations, and can deliver reproducible findings across different studies are needed.
RESULTS: We propose a set-based procedure for testing of differential expression and show that this set-based approach can produce more robust results by aggregating information across multiple, correlated genomic markers. Specifically, we adapt the Generalized Berk-Jones statistic to test for the transcription factors that may contribute to the progression of estrogen receptor positive breast cancer. We demonstrate the ability of our method to produce reproducible findings by applying the same analysis to 21 publicly available datasets, producing a similar list of significant transcription factors across most studies. Our Generalized Berk-Jones approach produces results that show improved consistency over three set-based testing algorithms: Generalized Higher Criticism, Gene Set Analysis and Gene Set Enrichment Analysis.
AVAILABILITY AND IMPLEMENTATION: Data are in the MetaGxBreast R package. Code is available at github.com/ryanrsun/gaynor_sun_GBJ_breast_cancer. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 31062858      PMCID: PMC6853697          DOI: 10.1093/bioinformatics/btz277

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  26 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  The Generalized Higher Criticism for Testing SNP-Set Effects in Genetic Association Studies.

Authors:  Ian Barnett; Rajarshi Mukherjee; Xihong Lin
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Enrichment map: a network-based method for gene-set enrichment visualization and interpretation.

Authors:  Daniele Merico; Ruth Isserlin; Oliver Stueker; Andrew Emili; Gary D Bader
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

5.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

6.  Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.

Authors:  Christine Desmedt; Benjamin Haibe-Kains; Pratyaksha Wirapati; Marc Buyse; Denis Larsimont; Gianluca Bontempi; Mauro Delorenzi; Martine Piccart; Christos Sotiriou
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

Review 7.  Breast cancer prognostic classification in the molecular era: the role of histological grade.

Authors:  Emad A Rakha; Jorge S Reis-Filho; Frederick Baehner; David J Dabbs; Thomas Decker; Vincenzo Eusebi; Stephen B Fox; Shu Ichihara; Jocelyne Jacquemier; Sunil R Lakhani; José Palacios; Andrea L Richardson; Stuart J Schnitt; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Sunil Badve; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2010-07-30       Impact factor: 6.466

8.  GRAPE: a pathway template method to characterize tissue-specific functionality from gene expression profiles.

Authors:  Michael I Klein; David F Stern; Hongyu Zhao
Journal:  BMC Bioinformatics       Date:  2017-06-26       Impact factor: 3.169

9.  Powerful gene set analysis in GWAS with the Generalized Berk-Jones statistic.

Authors:  Ryan Sun; Shirley Hui; Gary D Bader; Xihong Lin; Peter Kraft
Journal:  PLoS Genet       Date:  2019-03-15       Impact factor: 5.917

10.  Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists.

Authors:  Jonathan D Mosley; Ruth A Keri
Journal:  BMC Med Genomics       Date:  2008-04-25       Impact factor: 3.063

View more
  3 in total

1.  TWO-SIGMA-G: a new competitive gene set testing framework for scRNA-seq data accounting for inter-gene and cell-cell correlation.

Authors:  Eric Van Buren; Ming Hu; Liang Cheng; John Wrobel; Kirk Wilhelmsen; Lishan Su; Yun Li; Di Wu
Journal:  Brief Bioinform       Date:  2022-05-13       Impact factor: 13.994

2.  Multiple-Tissue Integrative Transcriptome-Wide Association Studies Discovered New Genes Associated With Amyotrophic Lateral Sclerosis.

Authors:  Lishun Xiao; Zhongshang Yuan; Siyi Jin; Ting Wang; Shuiping Huang; Ping Zeng
Journal:  Front Genet       Date:  2020-11-20       Impact factor: 4.599

3.  Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations.

Authors:  Louisa Helms; Silvia Marchiano; Ian B Stanaway; Tien-Ying Hsiang; Benjamin A Juliar; Shally Saini; Yan Ting Zhao; Akshita Khanna; Rajasree Menon; Fadhl Alakwaa; Carmen Mikacenic; Eric D Morrell; Mark M Wurfel; Matthias Kretzler; Jennifer L Harder; Charles E Murry; Jonathan Himmelfarb; Hannele Ruohola-Baker; Pavan K Bhatraju; Michael Gale; Benjamin S Freedman
Journal:  JCI Insight       Date:  2021-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.